Schoettler ML, French K, Harris A, Bryson E, Deeb L, Hudson Z, Obordo J, Chandrakasan S, Parikh S, Watkins B, Stenger E, Qayed M, Chonat S, Westbrook A, Switchenko J, Williams KM. D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. Am J Hematol. 2024 Mar;99(3):370-379. doi: 10.1002/ajh.27186. Epub 2024 Jan 2. PMID: 38164997.
Schoettler ML, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, Moissev I, Sanchez-Ortega I, Srivastava A, Atsuta Y, Carpenter P, Koreth J, Kroger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023 Mar;29(3):151-163. doi: 10.1016/j.jtct.2022.11.015. Epub 2022 Nov 25. PMID: 36442770; PMCID: PMC10119629.
Schoettler M, Stenger E, Spencer K, Lutterman D, Rumbika S, Jones J, Haight A, Parikh S, Qayed M, Watkins B, Krishnamurti L, Williams KM, Chonat S. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood Adv. 2023 May 9;7(9):1784-1795. doi: 10.1182/bloodadvances.2022008058. PMID: 36075028; PMCID: PMC10164784.
Schoettler ML, Dandoy CE, Harris A, Chan M, Tarquinio KM, Jodele S, Qayed M, Watkins B, Kamat P, Petrillo T, Obordo J, Higham CS, Dvorak CC, Westbrook A, Zinter MS, Williams KM. Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality. Front Oncol. 2023 Jul 20;13:1232621. doi: 10.3389/fonc.2023.1232621. PMID: 37546403; PMCID: PMC10399223.
Schoettler ML, Lehmann L, Kao PC, Chen N, Jodele S, Chonat S, Williams KM, London WB, Duncan C, Dandoy C. Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood Adv. 2024 Mar 12;8(5):1220-1233. doi: 10.1182/bloodadvances.2023011078. PMID: 38154068; PMCID: PMC10912836.
Schoettler ML, Patel S, Bryson E, Deeb L, Watkins B, Qayed M, Chandrakasan S, Fitch T, Silvis K, Jones J, Chonat S, Williams KM. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children. Transplant Cell Ther. 2023 Dec 23:S2666-6367(23)01751-7. doi: 10.1016/j.jtct.2023.12.017. Epub ahead of print. PMID: 38145741
Schoettler M, Lehmann LE, Margossian S, Lee M, Kean LS, Kao PC, Ma C, Duncan CN. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort. Blood Adv. 2020 Jun 9;4(11):2536-2547. doi: 10.1182/bloodadvances.2019001242. PMID: 32516415; PMCID: PMC7284101.
Schoettler ML, Bhatt H, Vasu S. A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy. Front Immunol. 2023 Feb 2;13:1064203. doi: 10.3389/fimmu.2022.1064203. PMID: 36818475; PMCID: PMC9933706.